Login / Signup
Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen-specific Th2 response.
Claudia Kitzmüller
Beatrice Jahn-Schmid
Tamar Kinaciyan
Barbara Bohle
Published in:
Allergy (2019)
Keyphrases
</>
allergic rhinitis